Cargando…

Case Series: Exacerbation of Insulin Resistance With Active COVID 19 Infection

Background: Severe hyperglycemia due to insulin resistance is associated with increased mortality due to induction of pro-inflammatory cytokines, immunodepression, impairing cellular function and healing. We describe 6 patients admitted with COVID19 pneumonia complicated with DKA requiring high dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jefferson, Kirupakaran, Johnathan, Cabezas, Fausto, Martinez, Jose, Dave, Paulomi, Williams, Belinda, Yau, Alice, Kim, Eunice, Bahtiyar, Gul, Rodriguez, Giovanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135413/
http://dx.doi.org/10.1210/jendso/bvab048.755
_version_ 1783695342547501056
author Li, Jefferson
Kirupakaran, Johnathan
Cabezas, Fausto
Martinez, Jose
Dave, Paulomi
Williams, Belinda
Yau, Alice
Kim, Eunice
Bahtiyar, Gul
Rodriguez, Giovanna
author_facet Li, Jefferson
Kirupakaran, Johnathan
Cabezas, Fausto
Martinez, Jose
Dave, Paulomi
Williams, Belinda
Yau, Alice
Kim, Eunice
Bahtiyar, Gul
Rodriguez, Giovanna
author_sort Li, Jefferson
collection PubMed
description Background: Severe hyperglycemia due to insulin resistance is associated with increased mortality due to induction of pro-inflammatory cytokines, immunodepression, impairing cellular function and healing. We describe 6 patients admitted with COVID19 pneumonia complicated with DKA requiring high dose insulin infusion. # 1 19 yo African American (AA) male with history of pre-DM and obesity (BMI 41 kg/m2) presented with polyuria, polydipsia, obtunded and intubated in ER. Labs showed pH 7.35, serum sodium (Na) 138 mmol/L, potassium (K) 6.8 mmol/L, chloride (Cl) 85 mmol/L, bicarbonate (HCO(3)) 10 mmol/L, glucose 1140 mg/dL, lactate 1.4 mmol/L, anion gap (AG) 43, Beta Hydroxybutyrate (BOH) > 4.50 mmol/L. A1c 13.4%. Placed on insulin drip at 29.5 U/hr or 5.7 U/kg/hr. Discharged on Detemir 60 U TID and Novolog 20 U TID ac. # 2 55 yo female with T2DM and obesity (BMI 37.42 kg/m(2)) presented with shortness of breath, intubated for hypoxia in ER. Labs showed pH 7.21, serum Na 138 mmol/L, K 5.6 mmol/L, Cl 101 mmol/L, HCO(3) 13 mmol/L, glucose 557 mg/dL, lactate 5 mmol/L, AG 24, BOH > 0.27 mmol/L. A1c 7.8%. Placed on insulin drip at 23 U/hr or 5 U/kg/hr. Died from multiorgan failure on day 7. # 3 75 yo Hispanic female with T2DM, HCV, post liver-kidney transplant on immunosuppressants, HTN presented with weakness. Intubated on day 6 for hypoxemia. Placed on stress dose steroids for transplant failure. BMI 30 kg/m(2). Labs on day 6 showed pH 6.98, serum Na 140 mmol/L, K 3.5 mmol/L, Cl 100 mmol/L, HCO(3) 20 mmol/L, glucose 590 mg/dL, AG 20, BOH 1.40 mmol/L. A1c 6.6% a year ago. Placed on insulin drip at 34 U/hr or 10.9 U/kg/hr. She developed ESRD requiring CRRT dialysis. She was made comfort care. Died on day 7. # 4 38 yo AA male with obesity (BMI 59.5 kg/m(2)) presenting with confusion, polyuria, polydipsia. Labs showed pH 7.22. serum Na 133 mmol/L, K 6.8 mmol/L, Cl 81 mmol/L, HCO(3) 15 mmol/L, glucose 1760 mg/dL, lactate 3.8 mmol/L, AG 37, BOH > 4.50 mmol/L. A1c 12.6%. Placed on insulin drip at 36 U/hr or 6 U/kg/hr. Discharged on Detemir 20 U qhs. # 5 27 yo AA female with T2DM, HTN and obesity (BMI 51 kg/m(2)), pituitary adenoma presented with seizures. Labs showed pH 7.15, serum Na 133 mmol/L, K 7.0 mmol/L, Cl 84 mmol/L, HCO(3) 7 mmol/L, serum glucose 951 mg/dL, lactate 1.6 mmol/L, AG 24, BOH >2.45 mmol/L. A1c >15%. Placed on insulin drip at 24 U/hr or 5 U/kg/hr. Died on day 5 from multiorgan failure. # 6 74 yo Hispanic female with T2DM, HTN and asthma presented with altered mental status. BMI 28 kg/m(2). Labs showed pH 7.25, serum Na 155 mmol/L, K 4.6 mmol/L, Cl 125 mmol/L, HCO(3) 17 mmol/L, serum glucose 779 mg/dL, lactate 2.6 mmol/L, AG 13, BOH >2.45 mmol/L. A1c > 15%. Placed on insulin drip at 24 U/hr or 3.5 U/kg/hr. Died on day 5. Conclusion: Patients with DM and obesity admitted with Covid19 infection presented with severe insulin resistance and poor outcomes. Cconsideration should be given to assessing therapeutic interventions to enhance insulin sensitivity and improve outcomes.
format Online
Article
Text
id pubmed-8135413
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-81354132021-05-21 Case Series: Exacerbation of Insulin Resistance With Active COVID 19 Infection Li, Jefferson Kirupakaran, Johnathan Cabezas, Fausto Martinez, Jose Dave, Paulomi Williams, Belinda Yau, Alice Kim, Eunice Bahtiyar, Gul Rodriguez, Giovanna J Endocr Soc Diabetes Mellitus and Glucose Metabolism Background: Severe hyperglycemia due to insulin resistance is associated with increased mortality due to induction of pro-inflammatory cytokines, immunodepression, impairing cellular function and healing. We describe 6 patients admitted with COVID19 pneumonia complicated with DKA requiring high dose insulin infusion. # 1 19 yo African American (AA) male with history of pre-DM and obesity (BMI 41 kg/m2) presented with polyuria, polydipsia, obtunded and intubated in ER. Labs showed pH 7.35, serum sodium (Na) 138 mmol/L, potassium (K) 6.8 mmol/L, chloride (Cl) 85 mmol/L, bicarbonate (HCO(3)) 10 mmol/L, glucose 1140 mg/dL, lactate 1.4 mmol/L, anion gap (AG) 43, Beta Hydroxybutyrate (BOH) > 4.50 mmol/L. A1c 13.4%. Placed on insulin drip at 29.5 U/hr or 5.7 U/kg/hr. Discharged on Detemir 60 U TID and Novolog 20 U TID ac. # 2 55 yo female with T2DM and obesity (BMI 37.42 kg/m(2)) presented with shortness of breath, intubated for hypoxia in ER. Labs showed pH 7.21, serum Na 138 mmol/L, K 5.6 mmol/L, Cl 101 mmol/L, HCO(3) 13 mmol/L, glucose 557 mg/dL, lactate 5 mmol/L, AG 24, BOH > 0.27 mmol/L. A1c 7.8%. Placed on insulin drip at 23 U/hr or 5 U/kg/hr. Died from multiorgan failure on day 7. # 3 75 yo Hispanic female with T2DM, HCV, post liver-kidney transplant on immunosuppressants, HTN presented with weakness. Intubated on day 6 for hypoxemia. Placed on stress dose steroids for transplant failure. BMI 30 kg/m(2). Labs on day 6 showed pH 6.98, serum Na 140 mmol/L, K 3.5 mmol/L, Cl 100 mmol/L, HCO(3) 20 mmol/L, glucose 590 mg/dL, AG 20, BOH 1.40 mmol/L. A1c 6.6% a year ago. Placed on insulin drip at 34 U/hr or 10.9 U/kg/hr. She developed ESRD requiring CRRT dialysis. She was made comfort care. Died on day 7. # 4 38 yo AA male with obesity (BMI 59.5 kg/m(2)) presenting with confusion, polyuria, polydipsia. Labs showed pH 7.22. serum Na 133 mmol/L, K 6.8 mmol/L, Cl 81 mmol/L, HCO(3) 15 mmol/L, glucose 1760 mg/dL, lactate 3.8 mmol/L, AG 37, BOH > 4.50 mmol/L. A1c 12.6%. Placed on insulin drip at 36 U/hr or 6 U/kg/hr. Discharged on Detemir 20 U qhs. # 5 27 yo AA female with T2DM, HTN and obesity (BMI 51 kg/m(2)), pituitary adenoma presented with seizures. Labs showed pH 7.15, serum Na 133 mmol/L, K 7.0 mmol/L, Cl 84 mmol/L, HCO(3) 7 mmol/L, serum glucose 951 mg/dL, lactate 1.6 mmol/L, AG 24, BOH >2.45 mmol/L. A1c >15%. Placed on insulin drip at 24 U/hr or 5 U/kg/hr. Died on day 5 from multiorgan failure. # 6 74 yo Hispanic female with T2DM, HTN and asthma presented with altered mental status. BMI 28 kg/m(2). Labs showed pH 7.25, serum Na 155 mmol/L, K 4.6 mmol/L, Cl 125 mmol/L, HCO(3) 17 mmol/L, serum glucose 779 mg/dL, lactate 2.6 mmol/L, AG 13, BOH >2.45 mmol/L. A1c > 15%. Placed on insulin drip at 24 U/hr or 3.5 U/kg/hr. Died on day 5. Conclusion: Patients with DM and obesity admitted with Covid19 infection presented with severe insulin resistance and poor outcomes. Cconsideration should be given to assessing therapeutic interventions to enhance insulin sensitivity and improve outcomes. Oxford University Press 2021-05-03 /pmc/articles/PMC8135413/ http://dx.doi.org/10.1210/jendso/bvab048.755 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Diabetes Mellitus and Glucose Metabolism
Li, Jefferson
Kirupakaran, Johnathan
Cabezas, Fausto
Martinez, Jose
Dave, Paulomi
Williams, Belinda
Yau, Alice
Kim, Eunice
Bahtiyar, Gul
Rodriguez, Giovanna
Case Series: Exacerbation of Insulin Resistance With Active COVID 19 Infection
title Case Series: Exacerbation of Insulin Resistance With Active COVID 19 Infection
title_full Case Series: Exacerbation of Insulin Resistance With Active COVID 19 Infection
title_fullStr Case Series: Exacerbation of Insulin Resistance With Active COVID 19 Infection
title_full_unstemmed Case Series: Exacerbation of Insulin Resistance With Active COVID 19 Infection
title_short Case Series: Exacerbation of Insulin Resistance With Active COVID 19 Infection
title_sort case series: exacerbation of insulin resistance with active covid 19 infection
topic Diabetes Mellitus and Glucose Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135413/
http://dx.doi.org/10.1210/jendso/bvab048.755
work_keys_str_mv AT lijefferson caseseriesexacerbationofinsulinresistancewithactivecovid19infection
AT kirupakaranjohnathan caseseriesexacerbationofinsulinresistancewithactivecovid19infection
AT cabezasfausto caseseriesexacerbationofinsulinresistancewithactivecovid19infection
AT martinezjose caseseriesexacerbationofinsulinresistancewithactivecovid19infection
AT davepaulomi caseseriesexacerbationofinsulinresistancewithactivecovid19infection
AT williamsbelinda caseseriesexacerbationofinsulinresistancewithactivecovid19infection
AT yaualice caseseriesexacerbationofinsulinresistancewithactivecovid19infection
AT kimeunice caseseriesexacerbationofinsulinresistancewithactivecovid19infection
AT bahtiyargul caseseriesexacerbationofinsulinresistancewithactivecovid19infection
AT rodriguezgiovanna caseseriesexacerbationofinsulinresistancewithactivecovid19infection